Can you work with proteases derived from patient samples?

Yes. We have experience handling protease-rich fluids (e.g., ascites, BAL, plasma) or tissue lysates and can process endogenous proteases within defined activity windows.

What if my protease has low activity or poor stability?

Creative Biolabs can optimize buffer conditions, cofactor supplements, and incubation strategies to support even low-activity enzymes. We also offer protease reconstitution from recombinant or purified forms if needed.

Are libraries random, targeted, or natural sequence-derived?

All three options are available. We can screen random libraries, consensus motif libraries, or libraries built from cleavable regions of known proteins.

Can this platform help design prodrugs or cleavable linkers?

Absolutely. Once protease specificity is known, Creative Biolabs can synthesize cleavable linkers or substrate-modified therapeutics and assess their cleavage profile in vitro or cellular systems.

Is your assay scalable to multiple proteases?

Yes. Our parallelized protocols support multiplex protease screening, enabling comparative profiling and off-target assessment.

How long does a typical project take?

Projects typically run 6-8 weeks from kickoff, depending on enzyme complexity and downstream needs. If cleavage validation or synthesis is added, timelines may extend by 1-2 weeks.

Protease Substrate based Library Screening Service

Introduction Our Services Workflow Platform Cases Advantages Deliverables FAQ Resources

Protease Substrate Screening: Identify Inhibitors or Activators of Key Protease Enzymes

Proteases are critical regulators of physiological and pathological processes, including cancer progression, inflammation, tissue remodeling, and neurodegeneration. Identifying their precise substrate preferences opens the door to targeted diagnostics, imaging agents, and therapeutic strategies. At Creative Biolabs, we offer protease substrate-based phage library screening services that allow clients to map protease cleavage specificity in a context-aware, high-resolution manner.

Unlike conventional screening platforms that focus on binding alone, our protease substrate screening leverages cleavage-driven selection to pinpoint peptide motifs and protein fragments preferentially processed by active proteases. Whether you're characterizing novel enzymes or developing protease-responsive therapeutics, Creative Biolabs delivers accurate, reproducible insights that translate into action.

What We Offer: Specialized Screening to Decode Proteolytic Activity

Creative Biolabs provides custom protease substrate screening using tailored phage display libraries that expose substrates to active enzymes, selecting cleaved or uncleaved sequences depending on the application. Our services include:

Screening peptide libraries against recombinant or native proteases

We can perform selections with purified recombinant enzymes or complex biological samples to capture physiologically relevant substrate profiles.

Library design optimization (linear, loop-constrained, positional scanning, or natural fragments)

Libraries are customized to fit your protease type and project goal, maximizing the diversity and functional relevance of screened peptides.

Cleavage-site enrichment analysis after protease digestion and phage recovery

Following enzymatic treatment, enriched peptide motifs are identified and analyzed to reveal preferred cleavage sequences.

In-solution or tissue-based protease exposure formats

Screening can be conducted in free-solution biochemical assays or on tissue sections to mimic in vivo enzyme–substrate interactions.

Enzyme kinetics analysis for selected substrates

Confirmed substrates are validated through detailed kinetic assays to determine catalytic efficiency and cleavage specificity.

Cross-screening for substrate selectivity and off-target profiling

Comparative testing against related enzymes ensures selectivity and minimizes unintended proteolysis, supporting therapeutic and diagnostic development.

We support both discovery-phase projects (e.g., unknown substrate mapping) and development-driven studies (e.g., creating protease-activated probes or therapeutics). Reach out to learn more.

Our Discovery Flow: How It Works Step by Step

Creative Biolabs follows a structured yet flexible workflow optimized for reproducibility and sensitivity:

Step 1. Project Planning

Consultation with Creative Biolabs' team to select the protease, library type, screening mode, and readout.
Step 2. Library Preparation

Synthesis or adaptation of phage display libraries containing potential cleavage motifs or substrate scaffolds. To accelerate your substrate development, you can directly select our ready-to-use premade Phage Display Protease-10A High-Affinity Tagged 10 mer Peptide Library!
Step 3. Protease Incubation

Exposure of the phage-displayed peptides to active protease under defined physiological or pathophysiological conditions.
Step 4. Selection Phase

Isolation of cleaved or uncleaved phage populations based on cleavage-dependent tags or capture mechanisms.
Step 5. Amplification & Iterative Screening

Optional second or third rounds to refine substrate specificity.
Step 6. Sequencing

High-throughput sequencing and motif analysis to identify enriched cleavage sequences.
Step 7. Optional Functional Testing

Substrate peptides may be validated using cleavage assays, functional conjugates, etc.

Learn more about our services here.

Our Platform: Built for Mechanistic Insight and Translational Potential

The Creative Biolabs protease screening platform stands out by offering more than a generic library-cleavage workflow. Our platform integrates structural insights, enzymatic profiling, and sample-context relevance into one pipeline.
Key platform advantages include:

Condition-customized screening: pH, cofactors, and inhibitors can be fine-tuned to simulate disease environments (e.g., tumor acidity or inflammation-associated oxidative stress).
Multiplex protease profiling: Compare substrate specificity across several proteases (e.g., MMPs, cathepsins, caspases) in parallel.
Tissue homogenate or plasma-based screening: Determine real-world relevance of cleavage motifs in complex biological samples.
Substrate mapping for engineered proteases: Useful in gene therapy and synthetic biology.

This platform also supports seamless integration with Creative Biolabs' other phage display and discovery tools:

Fig.8 In Vivo Selection. (Creative Biolabs AI)
In Vivo Phage Library Screening

Fig.9 Ex Vivo Analysis. (Creative Biolabs AI)
Ex Vivo Phage Display

Fig.10 Solid-phase Screening. (Creative Biolabs AI)
Solid-phase and Solution-based Library Screening

Fig.11 Cell-based Testing. (Creative Biolabs AI)
Cell-based Substrate Screening

Fig.12 Fast scFv Recovery. (Creative Biolabs AI)
Rapid scFv Recovery from Cleavage-Sensitive Selections

We'd love to hear from you if you're interested.

Case Study: Rapid Identification of a Novel Substrate for a Target Protease

We partnered with a client to accelerate their drug discovery program by rapidly identifying a high-affinity substrate peptide for their novel protease. This case study demonstrates our streamlined workflow from library screening to validated results.

Our Strategic Solution
We deployed our end-to-end Phage Display Screening platform, leveraging our proprietary peptide library.

Service Applied	Phage Display-Based Protease Substrate Screening
Platform Used	Protease-10A HiAffi™ 10-mer Peptide Library (Ready-to-use, high diversity)
Methodology	1. Rigorous Biopanning	Multi-round screening of the library against the target protease.
	2. Stringent Controls	Implemented a three-group design (Protease, Buffer Control, Depletion Control) to eliminate non-specific binders and ensure data integrity.
	3. Multi-level Validation	Employed ELISA for initial hit validation and Next-Generation Sequencing (NGS) for comprehensive analysis and final candidate confirmation.

Project Highlights & Results
Our robust methodology delivered actionable, high-confidence results, significantly advancing the client's research.

Result Category	Outcome
✅ Successful Enrichment	Achieved significant enrichment of specific phage clones after just a few screening rounds.
✅ High Hit Rate	From dozens of clones tested, over 33% showed specific interaction with the target protease in initial validation assays.
✅ Functional Confirmation	All prioritized positive clones were functionally confirmed for both binding affinity and proteolytic cleavage, proving their validity as true substrates.
✅ High-Confidence Deliverables	Delivered a final, rank-ordered list of substrate peptides, with top candidates cross-validated by both ELISA and high-abundance NGS data.

If you have any questions, we welcome your inquiries.

Why Choose Creative Biolabs: Scientific Precision, Flexible Execution

Clients trust Creative Biolabs because we combine advanced technology with project-specific adaptability. Here's what sets us apart:

Deep protease biology expertise

Our scientists specialize in metalloproteases, serine proteases, cysteine proteases, and more.

Custom library engineering

Not limited to commercial kits, we tailor libraries to fit unusual substrates or sequence contexts.

Cleavage-tag innovations

Use of engineered tags (e.g., biotin switch, His-tag removal) for reliable cleavage detection.

Real-world compatibility

Our workflows accommodate biological fluids, tissue extracts, or clinical samples.

Discover more by contacting us at your convenience.

Our Deliverables: From Sequences to Functional Substrates

With each project, Creative Biolabs provides high-quality deliverables designed to support downstream research or development pipelines:

Detailed technical report with screening conditions, enzyme kinetics (if applicable), and hit identification
High-throughput sequencing data (raw and processed)
Enriched motif or cleavage site patterns visualized and annotated
Functional performance validation data (if requested)
Optional synthesis of cleavage reporters or conjugates for in vitro or in vivo testing
Suggestions for future applications, target confirmation, or optimization strategies

Whether you're exploring new protease targets, validating disease-specific activity, or engineering protease-activated payloads, Creative Biolabs' Protease Substrate Screening Services provide the foundation you need. Contact us to schedule a discovery call or request a customized quote.

Common Questions: FAQs Answered

Q: Can you work with proteases derived from patient samples?
A: A: Yes. We have experience handling protease-rich fluids (e.g., ascites, BAL, plasma) or tissue lysates and can process endogenous proteases within defined activity windows.
Q: What if my protease has low activity or poor stability?
A: Creative Biolabs can optimize buffer conditions, cofactor supplements, and incubation strategies to support even low-activity enzymes. We also offer protease reconstitution from recombinant or purified forms if needed.
Q: Are libraries random, targeted, or natural sequence-derived?
A: All three options are available. We can screen random libraries, consensus motif libraries, or libraries built from cleavable regions of known proteins.
Q: Can this platform help design prodrugs or cleavable linkers?
A: Absolutely. Once protease specificity is known, Creative Biolabs can synthesize cleavable linkers or substrate-modified therapeutics and assess their cleavage profile in vitro or cellular systems.
Q: Is your assay scalable to multiple proteases?
A: Yes. Our parallelized protocols support multiplex protease screening, enabling comparative profiling and off-target assessment.
Q: How long does a typical project take?
A: Projects typically run 6–8 weeks from kickoff, depending on enzyme complexity and downstream needs. If cleavage validation or synthesis is added, timelines may extend by 1–2 weeks.